Amfenac Sodium Hydrate 25 mg | Purity Not Available
TargetMol
Amfenac Sodium Hydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.
More Information Supplier PageAmfenac Sodium Hydrate
Search Results
Amfenac Sodium Hydrate 50 mg | Purity Not Available
TargetMol
Amfenac Sodium Hydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.
More Information Supplier PageAmfenac Sodium Hydrate
Adenosine 5′-diphosphate 100 mg | 98.07%
TargetMol
Adenosine 5′-diphosphate induces human platelet aggregation and non-competitively blocks the stimulated human platelet adenylate cyclase.
More Information Supplier PageAdenosine 5′-diphosphate
Promestriene 5 mg | Purity Not Available
TargetMol
Promestriene (INN) is a synthetic estrogen and glucocorticoid used topically in a 1% cream formulation. It is described as a tropic agent and antiseborrheic.
More Information Supplier PagePromestriene
Rimantadine hydrochloride 100 mg | 99.73%
TargetMol
Rimantadine hydrochloride is an RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
More Information Supplier PageRimantadine hydrochloride
Rivastigmine tartrate 100 mg | 99.66%
TargetMol
Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
More Information Supplier PageRivastigmine tartrate
Rivastigmine tartrate 200 mg | 99.66%
TargetMol
Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
More Information Supplier PageRivastigmine tartrate
Rivastigmine tartrate 50 mg | 99.66%
TargetMol
Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
More Information Supplier PageRivastigmine tartrate
Ambrisentan 10 mg | 99.85%
TargetMol
Ambrisentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically apparent acute liver injury.
More Information Supplier PageAmbrisentan
Ambrisentan 5 mg | 99.85%
TargetMol
Ambrisentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically apparent acute liver injury.
More Information Supplier PageAmbrisentan